Greytown Advisors Inc. Illumina, Inc. Transaction History

Greytown Advisors Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $387 - $465	-2 Reduced 0.18%	1,110 $258,000
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $531 - $682	3 Added 0.27%	1,112 $212,000
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $544 - $1,104	3 Added 0.27%	1,109 $204,000
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $37,376 - $52,127	-123 Reduced 10.01%	1,106 $386,000
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $2,430 - $2,952	-7 Reduced 0.57%	1,229 $468,000
Q2 2021 Aug 16, 2021	BUY	$372.84 - $481.5 $26,844 - $34,668	72 Added 6.19%	1,236 $585,000
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $34,321 - $47,952	95 Added 8.89%	1,164 $447,000
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $12,586 - $15,951	43 Added 4.19%	1,069 $396,000
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $13,962 - $20,838	52 Added 5.34%	1,026 $317,000
Q2 2020 Aug 14, 2020	BUY	$256.46 - $373.01 $15,387 - $22,380	60 Added 6.56%	974 $361,000
Q1 2020 May 15, 2020	BUY	$209.2 - $335.53 $418 - $671	2 Added 0.22%	914 $250,000
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $243,358 - $344,945	912 New	912 $277,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Greytown Advisors Inc. with notifications on news.